Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  FUJIFILM Holdings Corp    4901   JP3814000000

FUJIFILM HOLDINGS CORP (4901)
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

FUJIFILM : Launches Eluxeo and Sets New Standard in Image Enhanced Endoscopy

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/13/2017 | 03:31pm CET

WAYNE, N.J., Oct. 12 -- Fujifilm USA issued the following news:

FUJIFILM Medical Systems U.S.A. Inc.,- Endoscopy today introduced ELUXEO(TM), a next-generation endoscopic video imaging system to its portfolio. The processor features 4 LED Multi-Light Technology to enhance visualization of areas of interest and mucosal surfaces in the gastrointestinal tract.

"Fujifilm continues to push the boundaries of innovation through the development of our ELUXEO platform. Providing physicians with the tools they need to enhance results, ELUXEO fulfills the need for enhanced visualization in endoscopy," said Keiichi Nagata, Division President, FUJIFILM Medical Systems U.S.A., Inc - Endoscopy.

The 4 LED Multi-Light Technology, developed to achieve optimal results in illumination, includes White Light as well as the new special light observation modes BLI (Blue Light Imaging) and LCI(R) (Linked Color Imaging). BLI outputs a high intensity ratio of blue-violet light, developed for high contrast imaging of microvessels. LCI is developed to intensify differences in red coloration for enhanced mucosal visualization through the use of advanced image processing technology. Observation modes can be switched using the scope button to toggle between White Light, BLI and LCI views.

Equipped with extended lamp life expectancy and an intuitive user interface, ELUXEO is setting a new standard in endoscopic imaging. Fujifilm will unveil ELUXEO this month at the World Congress of Gastroenterology at ACG 2017 on October 13-18 at the Orange County Convention Center in Orlando, Florida.

To learn more visit www.fujifilmendoscopy.com or visit booth #1201 at ACG.

Targeted News Service, source News Service

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FUJIFILM HOLDINGS CORP
02/22GLOBAL DIGITAL SINGLE LENS REFLEX CA : 99strategy.biz added a depth and professi..
AQ
02/22FUJIFILM : unit to build liposome drug manufacturing plant in Toyama
AQ
02/22FUJIFILM : New manufacturing facility to be built at Toyama Chemical, a Fujifilm..
PU
02/21FUJIFILM : Two Acuity F Presses Provide Fast Turnarounds and Increased Capabilit..
AQ
02/21FUJIFILM : Icahn derides sale of Xerox 'for a bowl of porridge'
AQ
02/20TAKEDA PHARMACEUTICAL : Japanese firms push into cell therapy
AQ
02/18FUJIFILM : Hypertherm, Fujifilm Dimatix Partner With Area High Schools
AQ
02/16FUJIFILM : Announces New Ultra-Compact Cinema Lenses, Fujinon MKX18-55mmt2.9 and..
AQ
02/15FUJIFILM : The X-H1 is Fujifilm's most advanced X Series camera ever
AQ
02/15FUJIFILM X-H1 VS X-T2 : 8 key differences you need to know
AQ
More news
News from SeekingAlpha
02/16NIKKEI : Icahn, Deason cut Xerox stake after Fujifilm deal 
02/14WALL STREET BREAKFAST : Inflation Data Under The Microscope 
02/14Deason sues to block Xerox-Fujifilm deal 
02/13WALL STREET BREAKFAST : U.S. Stock Recovery In Doubt? 
02/13Icahn, Deason urge Xerox shareholders to oppose deal 
Financials ( JPY)
Sales 2018 2 454 B
EBIT 2018 -
Net income 2018 132 B
Finance 2018 300 B
Yield 2018 1,75%
P/E ratio 2018 14,32
P/E ratio 2019 13,90
EV / Sales 2018 0,79x
EV / Sales 2019 0,73x
Capitalization 2 243 B
Chart FUJIFILM HOLDINGS CORP
Duration : Period :
FUJIFILM Holdings Corp Technical Analysis Chart | 4901 | JP3814000000 | 4-Traders
Technical analysis trends FUJIFILM HOLDINGS CORP
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 5 114  JPY
Spread / Average Target 17%
EPS Revisions
Managers
NameTitle
Shigetaka Komori Chairman & Group Chief Executive Officer
Kenji Sukeno President, Group COO & Representative Director
Shigenobu Inenaga Head-Consolidated Finance & Administration
Yuzo Toda Director & Chief Technology Officer
Kouichi Tamai Director & Executive Officer
Sector and Competitors
1st jan.Capitalization (M$)
FUJIFILM HOLDINGS CORP-8.14%20 857
CANON INC-7.25%49 641
SEIKO EPSON CORPORATION-24.10%7 705
BROTHER INDUSTRIES LTD-8.69%6 462
KONICA MINOLTA INC-12.56%4 567
PITNEY BOWES INC.10.55%2 293